Analysis of gene amplification-loss and methylation associated with progression to metastatic colorectal cancer [ 2008 - 2010 ]

Research Grant

Researchers: A/Pr Lara Lipton (Principal investigator) ,  A/Pr Oliver Sieber ,  Dr Garry Hannan ,  Dr Peter Molloy ,  Prof Peter Gibbs
View all 6 related researchers

Brief description Many bowel cancers can be removed by surgery, but in many cases the cancer reoccurs. While chemotherapy can reduce the chance of recurrence, it can produce significant side effects. Currently there are few markers to indicate change of recurrence, therefore deciding who should, or should not receive chemotherapy is difficult to decide. This study will analyse differences in DNA from patients that do and do not relapse, to guide future decisions on patients who will benefit from chemotherapy.

Funding Amount $AUD 620,197.64

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant